|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/10 | |
| A61K 47/36 | |||
| A61K 31/00 |
| (11) | Number of the document | 1706095 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05705784.6 |
| Date of filing the European patent application | 2005-01-14 | |
| (97) | Date of publication of the European application | 2006-10-04 |
| (45) | Date of publication and mention of the grant of the patent | 2008-12-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/001371 |
| Date | 2005-01-14 |
| (87) | Number | WO 2005/072701 |
| Date | 2005-08-11 |
| (30) | Number | Date | Country code |
| 537620 P | 2004-01-20 | US |
| (72) |
HUGHES, Patrick, M., US
OLEJNIK, Orest, US
WHITCUP, Scott, M., US
BURKE, James, A., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine CA 92612,
US
|
| (54) | COMPOSITIONS FOR LOCALIZED THERAPY OF THE EYE, COMPRISING PREFERABLY TRIAMCINOLONE ACETONIDE AND HYALURONIC ACID |
| COMPOSITIONS FOR LOCALIZED THERAPY OF THE EYE, COMPRISING PREFERABLY TRIAMCINOLONE ACETONIDE AND HYALURONIC ACID |